APO Research, Inc.

APO RESEARCH · REPORT

Agrobacterium tumefaciens Competent Cells

Selected research

Market Outlook & Growth Opportunities

Global Agrobacterium tumefaciens Competent Cells Market Outlook and Growth Opportunities 2026

Market perspective

The global Agrobacterium tumefaciens Competent Cells market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Agrobacterium tumefaciens Competent Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Agrobacterium tumefaciens Competent Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Agrobacterium tumefaciens Competent Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Agrobacterium tumefaciens Competent Cells market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Agrobacterium tumefaciens Competent Cells market include Thermo Fisher Scientific, Merck KGaA, Beijing TransGen Biotech, Zymo Research, Yeastern Biotech, Takara Bio, QIAGEN N.V., Promega Corporation and OriGene Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Agrobacterium tumefaciens Competent Cells market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Agrobacterium tumefaciens Competent Cells and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Agrobacterium tumefaciens Competent Cells sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Agrobacterium tumefaciens Competent Cells market size, projected growth trends, production technologies, key applications, and end-use industries.

Agrobacterium tumefaciens Competent Cells Segment by Company

Thermo Fisher Scientific

Merck KGaA

Beijing TransGen Biotech

Zymo Research

Yeastern Biotech

Takara Bio

QIAGEN N.V.

Promega Corporation

OriGene Technologies

New England Biolabs

Lucigen

GeneScript Corporation

Bio-Rad Laboratories

Bioline

Agilent Technologies

Agrobacterium tumefaciens Competent Cells Segment by Type

50*100μl

20*100μl

100*100μl

Other

Agrobacterium tumefaciens Competent Cells Segment by Application

Mutagenesis

Single-Stranded Dna Production

Cre-lox recombination (PIR1/PIR2)

Bacmid creation

Agrobacterium tumefaciens Competent Cells Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Agrobacterium tumefaciens Competent Cells status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Agrobacterium tumefaciens Competent Cells market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Agrobacterium tumefaciens Competent Cells significant trends, drivers, influence factors in global and regions.

6. To analyze Agrobacterium tumefaciens Competent Cells competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Agrobacterium tumefaciens Competent Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Agrobacterium tumefaciens Competent Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Agrobacterium tumefaciens Competent Cells.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Agrobacterium tumefaciens Competent Cells market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Agrobacterium tumefaciens Competent Cells industry.

Chapter 3: Detailed analysis of Agrobacterium tumefaciens Competent Cells manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Agrobacterium tumefaciens Competent Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Agrobacterium tumefaciens Competent Cells in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Agrobacterium tumefaciens Competent Cells Industry Trends Table 2. Agrobacterium tumefaciens Competent Cells Industry Drivers Table 3. Agrobacterium tumefaciens Competent Cells Industry Opportunities and Challenges Table 4. Agrobacterium tumefaciens Competent Cells Industry Restraints Table 5. Global Agrobacterium tumefaciens Competent Cells Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Agrobacterium tumefaciens Competent Cells Revenue Share by Company (2021-2026) Table 7. Global Agrobacterium tumefaciens Competent Cells Sales Volume by Company (k tons) & (2021-2026) Table 8. Global Agrobacterium tumefaciens Competent Cells Sales Volume Share by Company (2021-2026) Table 9. Global Agrobacterium tumefaciens Competent Cells Average Price (US$/ton) of Company (2021-2026) Table 10. Global Agrobacterium tumefaciens Competent Cells Company Ranking, (2024-2026) & (USD Million) Table 11. Global Agrobacterium tumefaciens Competent Cells Key Company Manufacturing Base & Headquarters Table 12. Global Agrobacterium tumefaciens Competent Cells Company, Product Type & Application Table 13. Global Agrobacterium tumefaciens Competent Cells Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Agrobacterium tumefaciens Competent Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 50*100μl Table 18. Significant Companies of 20*100μl Table 19. Significant Companies of 100*100μl Table 20. Significant Companies of Other Table 21. Global Agrobacterium tumefaciens Competent Cells Sales Volume by Type 2021 VS 2025 VS 2032 (k tons) Table 22. Global Agrobacterium tumefaciens Competent Cells Sales Volume by Type (2021-2026) & (k tons) Table 23. Global Agrobacterium tumefaciens Competent Cells Sales Volume by Type (2027-2032) & (k tons) Table 24. Global Agrobacterium tumefaciens Competent Cells Sales Volume Share by Type (2021-2026) Table 25. Global Agrobacterium tumefaciens Competent Cells Sales Volume Share by Type (2027-2032) Table 26. Global Agrobacterium tumefaciens Competent Cells Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Agrobacterium tumefaciens Competent Cells Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Agrobacterium tumefaciens Competent Cells Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Agrobacterium tumefaciens Competent Cells Sales Value Share by Type (2021-2026) Table 30. Global Agrobacterium tumefaciens Competent Cells Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Mutagenesis Table 32. Significant Companies of Single-Stranded Dna Production Table 33. Significant Companies of Cre-lox recombination (PIR1/PIR2) Table 34. Significant Companies of Bacmid creation Table 35. Global Agrobacterium tumefaciens Competent Cells Sales Volume by Application 2021 VS 2025 VS 2032 (k tons) Table 36. Global Agrobacterium tumefaciens Competent Cells Sales Volume by Application (2021-2026) & (k tons) Table 37. Global Agrobacterium tumefaciens Competent Cells Sales Volume by Application (2027-2032) & (k tons) Table 38. Global Agrobacterium tumefaciens Competent Cells Sales Volume Share by Application (2021-2026) Table 39. Global Agrobacterium tumefaciens Competent Cells Sales Volume Share by Application (2027-2032) Table 40. Global Agrobacterium tumefaciens Competent Cells Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Agrobacterium tumefaciens Competent Cells Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Agrobacterium tumefaciens Competent Cells Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Agrobacterium tumefaciens Competent Cells Sales Value Share by Application (2021-2026) Table 44. Global Agrobacterium tumefaciens Competent Cells Sales Value Share by Application (2027-2032) Table 45. Global Agrobacterium tumefaciens Competent Cells Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 46. Global Agrobacterium tumefaciens Competent Cells Sales by Region (2021-2026) & (k tons) Table 47. Global Agrobacterium tumefaciens Competent Cells Sales Market Share by Region (2021-2026) Table 48. Global Agrobacterium tumefaciens Competent Cells Sales by Region (2027-2032) & (k tons) Table 49. Global Agrobacterium tumefaciens Competent Cells Sales Market Share by Region (2027-2032) Table 50. Global Agrobacterium tumefaciens Competent Cells Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Agrobacterium tumefaciens Competent Cells Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Agrobacterium tumefaciens Competent Cells Sales Value Share by Region (2021-2026) Table 53. Global Agrobacterium tumefaciens Competent Cells Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Agrobacterium tumefaciens Competent Cells Sales Value Share by Region (2027-2032) Table 55. Global Agrobacterium tumefaciens Competent Cells Market Average Price (US$/ton) by Region (2021-2026) Table 56. Global Agrobacterium tumefaciens Competent Cells Market Average Price (US$/ton) by Region (2027-2032) Table 57. Global Agrobacterium tumefaciens Competent Cells Sales by Country: 2021 VS 2025 VS 2032 (k tons) Table 58. Global Agrobacterium tumefaciens Competent Cells Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Agrobacterium tumefaciens Competent Cells Sales by Country (2021-2026) & (k tons) Table 60. Global Agrobacterium tumefaciens Competent Cells Sales Market Share by Country (2021-2026) Table 61. Global Agrobacterium tumefaciens Competent Cells Sales by Country (2027-2032) & (k tons) Table 62. Global Agrobacterium tumefaciens Competent Cells Sales Market Share by Country (2027-2032) Table 63. Global Agrobacterium tumefaciens Competent Cells Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Agrobacterium tumefaciens Competent Cells Sales Value Market Share by Country (2021-2026) Table 65. Global Agrobacterium tumefaciens Competent Cells Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Agrobacterium tumefaciens Competent Cells Sales Value Market Share by Country (2027-2032) Table 67. Thermo Fisher Scientific Company Information Table 68. Thermo Fisher Scientific Business Overview Table 69. Thermo Fisher Scientific Agrobacterium tumefaciens Competent Cells Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 70. Thermo Fisher Scientific Agrobacterium tumefaciens Competent Cells Product Portfolio Table 71. Thermo Fisher Scientific Recent Development Table 72. Merck KGaA Company Information Table 73. Merck KGaA Business Overview Table 74. Merck KGaA Agrobacterium tumefaciens Competent Cells Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 75. Merck KGaA Agrobacterium tumefaciens Competent Cells Product Portfolio Table 76. Merck KGaA Recent Development Table 77. Beijing TransGen Biotech Company Information Table 78. Beijing TransGen Biotech Business Overview Table 79. Beijing TransGen Biotech Agrobacterium tumefaciens Competent Cells Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 80. Beijing TransGen Biotech Agrobacterium tumefaciens Competent Cells Product Portfolio Table 81. Beijing TransGen Biotech Recent Development Table 82. Zymo Research Company Information Table 83. Zymo Research Business Overview Table 84. Zymo Research Agrobacterium tumefaciens Competent Cells Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 85. Zymo Research Agrobacterium tumefaciens Competent Cells Product Portfolio Table 86. Zymo Research Recent Development Table 87. Yeastern Biotech Company Information Table 88. Yeastern Biotech Business Overview Table 89. Yeastern Biotech Agrobacterium tumefaciens Competent Cells Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 90. Yeastern Biotech Agrobacterium tumefaciens Competent Cells Product Portfolio Table 91. Yeastern Biotech Recent Development Table 92. Takara Bio Company Information Table 93. Takara Bio Business Overview Table 94. Takara Bio Agrobacterium tumefaciens Competent Cells Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 95. Takara Bio Agrobacterium tumefaciens Competent Cells Product Portfolio Table 96. Takara Bio Recent Development Table 97. QIAGEN N.V. Company Information Table 98. QIAGEN N.V. Business Overview Table 99. QIAGEN N.V. Agrobacterium tumefaciens Competent Cells Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 100. QIAGEN N.V. Agrobacterium tumefaciens Competent Cells Product Portfolio Table 101. QIAGEN N.V. Recent Development Table 102. Promega Corporation Company Information Table 103. Promega Corporation Business Overview Table 104. Promega Corporation Agrobacterium tumefaciens Competent Cells Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 105. Promega Corporation Agrobacterium tumefaciens Competent Cells Product Portfolio Table 106. Promega Corporation Recent Development Table 107. OriGene Technologies Company Information Table 108. OriGene Technologies Business Overview Table 109. OriGene Technologies Agrobacterium tumefaciens Competent Cells Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 110. OriGene Technologies Agrobacterium tumefaciens Competent Cells Product Portfolio Table 111. OriGene Technologies Recent Development Table 112. New England Biolabs Company Information Table 113. New England Biolabs Business Overview Table 114. New England Biolabs Agrobacterium tumefaciens Competent Cells Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 115. New England Biolabs Agrobacterium tumefaciens Competent Cells Product Portfolio Table 116. New England Biolabs Recent Development Table 117. Lucigen Company Information Table 118. Lucigen Business Overview Table 119. Lucigen Agrobacterium tumefaciens Competent Cells Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 120. Lucigen Agrobacterium tumefaciens Competent Cells Product Portfolio Table 121. Lucigen Recent Development Table 122. GeneScript Corporation Company Information Table 123. GeneScript Corporation Business Overview Table 124. GeneScript Corporation Agrobacterium tumefaciens Competent Cells Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 125. GeneScript Corporation Agrobacterium tumefaciens Competent Cells Product Portfolio Table 126. GeneScript Corporation Recent Development Table 127. Bio-Rad Laboratories Company Information Table 128. Bio-Rad Laboratories Business Overview Table 129. Bio-Rad Laboratories Agrobacterium tumefaciens Competent Cells Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 130. Bio-Rad Laboratories Agrobacterium tumefaciens Competent Cells Product Portfolio Table 131. Bio-Rad Laboratories Recent Development Table 132. Bioline Company Information Table 133. Bioline Business Overview Table 134. Bioline Agrobacterium tumefaciens Competent Cells Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 135. Bioline Agrobacterium tumefaciens Competent Cells Product Portfolio Table 136. Bioline Recent Development Table 137. Agilent Technologies Company Information Table 138. Agilent Technologies Business Overview Table 139. Agilent Technologies Agrobacterium tumefaciens Competent Cells Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 140. Agilent Technologies Agrobacterium tumefaciens Competent Cells Product Portfolio Table 141. Agilent Technologies Recent Development Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Agrobacterium tumefaciens Competent Cells Distributors List Table 145. Agrobacterium tumefaciens Competent Cells Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Agrobacterium tumefaciens Competent Cells Product Image Figure 2. Global Agrobacterium tumefaciens Competent Cells Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Agrobacterium tumefaciens Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 4. Global Agrobacterium tumefaciens Competent Cells Sales (2021-2032) & (k tons) Figure 5. Global Agrobacterium tumefaciens Competent Cells Sales Average Price (US$/ton) & (2021-2032) Figure 6. Global Agrobacterium tumefaciens Competent Cells Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 50*100μl Image Figure 10. 20*100μl Image Figure 11. 100*100μl Image Figure 12. Other Image Figure 13. Global Agrobacterium tumefaciens Competent Cells Sales Volume by Type (2021 VS 2025 VS 2032) & (k tons) Figure 14. Global Agrobacterium tumefaciens Competent Cells Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Agrobacterium tumefaciens Competent Cells Sales Volume Share by Type (2021-2032) Figure 16. Global Agrobacterium tumefaciens Competent Cells Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Agrobacterium tumefaciens Competent Cells Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Agrobacterium tumefaciens Competent Cells Sales Value Share by Type (2021-2032) Figure 19. Mutagenesis Image Figure 20. Single-Stranded Dna Production Image Figure 21. Cre-lox recombination (PIR1/PIR2) Image Figure 22. Bacmid creation Image Figure 23. Global Agrobacterium tumefaciens Competent Cells Sales Volume by Application (2021 VS 2025 VS 2032) & (k tons) Figure 24. Global Agrobacterium tumefaciens Competent Cells Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Agrobacterium tumefaciens Competent Cells Sales Volume Share by Application (2021-2032) Figure 26. Global Agrobacterium tumefaciens Competent Cells Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Agrobacterium tumefaciens Competent Cells Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Agrobacterium tumefaciens Competent Cells Sales Value Share by Application (2021-2032) Figure 29. Global Agrobacterium tumefaciens Competent Cells Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 30. Global Agrobacterium tumefaciens Competent Cells Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Agrobacterium tumefaciens Competent Cells Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Agrobacterium tumefaciens Competent Cells Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Agrobacterium tumefaciens Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 34. North America Agrobacterium tumefaciens Competent Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Agrobacterium tumefaciens Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Agrobacterium tumefaciens Competent Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Agrobacterium tumefaciens Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Agrobacterium tumefaciens Competent Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Agrobacterium tumefaciens Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 40. South America Agrobacterium tumefaciens Competent Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Agrobacterium tumefaciens Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Agrobacterium tumefaciens Competent Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Agrobacterium tumefaciens Competent Cells Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Agrobacterium tumefaciens Competent Cells Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • 50*100μl
  • 20*100μl
  • 100*100μl
  • Other
Applications
  • Mutagenesis
  • Single-Stranded Dna Production
  • Cre-lox recombination (PIR1/PIR2)
  • Bacmid creation
Companies covered
  • Thermo Fisher Scientific
  • Merck KGaA
  • Beijing TransGen Biotech
  • Zymo Research
  • Yeastern Biotech
  • Takara Bio
  • QIAGEN N.V.
  • Promega Corporation
  • OriGene Technologies
  • New England Biolabs
  • Lucigen
  • GeneScript Corporation
  • Bio-Rad Laboratories
  • Bioline
  • Agilent Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Agrobacterium tumefaciens Competent Cells Sales Value (2021-2032)
  4. 1.2.2 Global Agrobacterium tumefaciens Competent Cells Sales Volume (2021-2032)
  5. 1.2.3 Global Agrobacterium tumefaciens Competent Cells Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Agrobacterium tumefaciens Competent Cells Market Dynamics
  1. 2.1 Agrobacterium tumefaciens Competent Cells Industry Trends
  2. 2.2 Agrobacterium tumefaciens Competent Cells Industry Drivers
  3. 2.3 Agrobacterium tumefaciens Competent Cells Industry Opportunities and Challenges
  4. 2.4 Agrobacterium tumefaciens Competent Cells Industry Restraints
3 Agrobacterium tumefaciens Competent Cells Market by Company
  1. 3.1 Global Agrobacterium tumefaciens Competent Cells Company Revenue Ranking in 2025
  2. 3.2 Global Agrobacterium tumefaciens Competent Cells Revenue by Company (2021-2026)
  3. 3.3 Global Agrobacterium tumefaciens Competent Cells Sales Volume by Company (2021-2026)
  4. 3.4 Global Agrobacterium tumefaciens Competent Cells Average Price by Company (2021-2026)
  5. 3.5 Global Agrobacterium tumefaciens Competent Cells Company Ranking (2024-2026)
  6. 3.6 Global Agrobacterium tumefaciens Competent Cells Company Manufacturing Base and Headquarters
  7. 3.7 Global Agrobacterium tumefaciens Competent Cells Company Product Type and Application
  8. 3.8 Global Agrobacterium tumefaciens Competent Cells Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Agrobacterium tumefaciens Competent Cells Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Agrobacterium tumefaciens Competent Cells Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Agrobacterium tumefaciens Competent Cells Market by Type
  1. 4.1 Agrobacterium tumefaciens Competent Cells Type Introduction
  2. 4.1.1 50*100μl
  3. 4.1.2 20*100μl
  4. 4.1.3 100*100μl
  5. 4.1.4 Other
  6. 4.2 Global Agrobacterium tumefaciens Competent Cells Sales Volume by Type
  7. 4.2.1 Global Agrobacterium tumefaciens Competent Cells Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Agrobacterium tumefaciens Competent Cells Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Agrobacterium tumefaciens Competent Cells Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Agrobacterium tumefaciens Competent Cells Sales Value by Type
  11. 4.3.1 Global Agrobacterium tumefaciens Competent Cells Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Agrobacterium tumefaciens Competent Cells Sales Value by Type (2021-2032)
  13. 4.3.3 Global Agrobacterium tumefaciens Competent Cells Sales Value Share by Type (2021-2032)
5 Agrobacterium tumefaciens Competent Cells Market by Application
  1. 5.1 Agrobacterium tumefaciens Competent Cells Application Introduction
  2. 5.1.1 Mutagenesis
  3. 5.1.2 Single-Stranded Dna Production
  4. 5.1.3 Cre-lox recombination (PIR1/PIR2)
  5. 5.1.4 Bacmid creation
  6. 5.2 Global Agrobacterium tumefaciens Competent Cells Sales Volume by Application
  7. 5.2.1 Global Agrobacterium tumefaciens Competent Cells Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Agrobacterium tumefaciens Competent Cells Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Agrobacterium tumefaciens Competent Cells Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Agrobacterium tumefaciens Competent Cells Sales Value by Application
  11. 5.3.1 Global Agrobacterium tumefaciens Competent Cells Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Agrobacterium tumefaciens Competent Cells Sales Value by Application (2021-2032)
  13. 5.3.3 Global Agrobacterium tumefaciens Competent Cells Sales Value Share by Application (2021-2032)
6 Agrobacterium tumefaciens Competent Cells Regional Sales and Value Analysis
  1. 6.1 Global Agrobacterium tumefaciens Competent Cells Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Agrobacterium tumefaciens Competent Cells Sales by Region (2021-2032)
  3. 6.2.1 Global Agrobacterium tumefaciens Competent Cells Sales by Region: 2021-2026
  4. 6.2.2 Global Agrobacterium tumefaciens Competent Cells Sales by Region (2027-2032)
  5. 6.3 Global Agrobacterium tumefaciens Competent Cells Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Agrobacterium tumefaciens Competent Cells Sales Value by Region (2021-2032)
  7. 6.4.1 Global Agrobacterium tumefaciens Competent Cells Sales Value by Region: 2021-2026
  8. 6.4.2 Global Agrobacterium tumefaciens Competent Cells Sales Value by Region (2027-2032)
  9. 6.5 Global Agrobacterium tumefaciens Competent Cells Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Agrobacterium tumefaciens Competent Cells Sales Value (2021-2032)
  12. 6.6.2 North America Agrobacterium tumefaciens Competent Cells Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Agrobacterium tumefaciens Competent Cells Sales Value (2021-2032)
  15. 6.7.2 Europe Agrobacterium tumefaciens Competent Cells Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Agrobacterium tumefaciens Competent Cells Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Agrobacterium tumefaciens Competent Cells Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Agrobacterium tumefaciens Competent Cells Sales Value (2021-2032)
  21. 6.9.2 South America Agrobacterium tumefaciens Competent Cells Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Agrobacterium tumefaciens Competent Cells Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Agrobacterium tumefaciens Competent Cells Sales Value Share by Country, 2025 VS 2032
7 Agrobacterium tumefaciens Competent Cells Country-level Sales and Value Analysis
  1. 7.1 Global Agrobacterium tumefaciens Competent Cells Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Agrobacterium tumefaciens Competent Cells Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Agrobacterium tumefaciens Competent Cells Sales by Country (2021-2032)
  4. 7.3.1 Global Agrobacterium tumefaciens Competent Cells Sales by Country (2021-2026)
  5. 7.3.2 Global Agrobacterium tumefaciens Competent Cells Sales by Country (2027-2032)
  6. 7.4 Global Agrobacterium tumefaciens Competent Cells Sales Value by Country (2021-2032)
  7. 7.4.1 Global Agrobacterium tumefaciens Competent Cells Sales Value by Country (2021-2026)
  8. 7.4.2 Global Agrobacterium tumefaciens Competent Cells Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Agrobacterium tumefaciens Competent Cells Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Agrobacterium tumefaciens Competent Cells Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Agrobacterium tumefaciens Competent Cells Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Agrobacterium tumefaciens Competent Cells Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Agrobacterium tumefaciens Competent Cells Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Merck KGaA
  8. 8.2.1 Merck KGaA Company Information
  9. 8.2.2 Merck KGaA Business Overview
  10. 8.2.3 Merck KGaA Agrobacterium tumefaciens Competent Cells Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck KGaA Agrobacterium tumefaciens Competent Cells Product Portfolio
  12. 8.2.5 Merck KGaA Recent Developments
  13. 8.3 Beijing TransGen Biotech
  14. 8.3.1 Beijing TransGen Biotech Company Information
  15. 8.3.2 Beijing TransGen Biotech Business Overview
  16. 8.3.3 Beijing TransGen Biotech Agrobacterium tumefaciens Competent Cells Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Beijing TransGen Biotech Agrobacterium tumefaciens Competent Cells Product Portfolio
  18. 8.3.5 Beijing TransGen Biotech Recent Developments
  19. 8.4 Zymo Research
  20. 8.4.1 Zymo Research Company Information
  21. 8.4.2 Zymo Research Business Overview
  22. 8.4.3 Zymo Research Agrobacterium tumefaciens Competent Cells Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Zymo Research Agrobacterium tumefaciens Competent Cells Product Portfolio
  24. 8.4.5 Zymo Research Recent Developments
  25. 8.5 Yeastern Biotech
  26. 8.5.1 Yeastern Biotech Company Information
  27. 8.5.2 Yeastern Biotech Business Overview
  28. 8.5.3 Yeastern Biotech Agrobacterium tumefaciens Competent Cells Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Yeastern Biotech Agrobacterium tumefaciens Competent Cells Product Portfolio
  30. 8.5.5 Yeastern Biotech Recent Developments
  31. 8.6 Takara Bio
  32. 8.6.1 Takara Bio Company Information
  33. 8.6.2 Takara Bio Business Overview
  34. 8.6.3 Takara Bio Agrobacterium tumefaciens Competent Cells Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Takara Bio Agrobacterium tumefaciens Competent Cells Product Portfolio
  36. 8.6.5 Takara Bio Recent Developments
  37. 8.7 QIAGEN N.V.
  38. 8.7.1 QIAGEN N.V. Company Information
  39. 8.7.2 QIAGEN N.V. Business Overview
  40. 8.7.3 QIAGEN N.V. Agrobacterium tumefaciens Competent Cells Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 QIAGEN N.V. Agrobacterium tumefaciens Competent Cells Product Portfolio
  42. 8.7.5 QIAGEN N.V. Recent Developments
  43. 8.8 Promega Corporation
  44. 8.8.1 Promega Corporation Company Information
  45. 8.8.2 Promega Corporation Business Overview
  46. 8.8.3 Promega Corporation Agrobacterium tumefaciens Competent Cells Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Promega Corporation Agrobacterium tumefaciens Competent Cells Product Portfolio
  48. 8.8.5 Promega Corporation Recent Developments
  49. 8.9 OriGene Technologies
  50. 8.9.1 OriGene Technologies Company Information
  51. 8.9.2 OriGene Technologies Business Overview
  52. 8.9.3 OriGene Technologies Agrobacterium tumefaciens Competent Cells Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 OriGene Technologies Agrobacterium tumefaciens Competent Cells Product Portfolio
  54. 8.9.5 OriGene Technologies Recent Developments
  55. 8.10 New England Biolabs
  56. 8.10.1 New England Biolabs Company Information
  57. 8.10.2 New England Biolabs Business Overview
  58. 8.10.3 New England Biolabs Agrobacterium tumefaciens Competent Cells Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 New England Biolabs Agrobacterium tumefaciens Competent Cells Product Portfolio
  60. 8.10.5 New England Biolabs Recent Developments
  61. 8.11 Lucigen
  62. 8.11.1 Lucigen Company Information
  63. 8.11.2 Lucigen Business Overview
  64. 8.11.3 Lucigen Agrobacterium tumefaciens Competent Cells Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Lucigen Agrobacterium tumefaciens Competent Cells Product Portfolio
  66. 8.11.5 Lucigen Recent Developments
  67. 8.12 GeneScript Corporation
  68. 8.12.1 GeneScript Corporation Company Information
  69. 8.12.2 GeneScript Corporation Business Overview
  70. 8.12.3 GeneScript Corporation Agrobacterium tumefaciens Competent Cells Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 GeneScript Corporation Agrobacterium tumefaciens Competent Cells Product Portfolio
  72. 8.12.5 GeneScript Corporation Recent Developments
  73. 8.13 Bio-Rad Laboratories
  74. 8.13.1 Bio-Rad Laboratories Company Information
  75. 8.13.2 Bio-Rad Laboratories Business Overview
  76. 8.13.3 Bio-Rad Laboratories Agrobacterium tumefaciens Competent Cells Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Bio-Rad Laboratories Agrobacterium tumefaciens Competent Cells Product Portfolio
  78. 8.13.5 Bio-Rad Laboratories Recent Developments
  79. 8.14 Bioline
  80. 8.14.1 Bioline Company Information
  81. 8.14.2 Bioline Business Overview
  82. 8.14.3 Bioline Agrobacterium tumefaciens Competent Cells Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Bioline Agrobacterium tumefaciens Competent Cells Product Portfolio
  84. 8.14.5 Bioline Recent Developments
  85. 8.15 Agilent Technologies
  86. 8.15.1 Agilent Technologies Company Information
  87. 8.15.2 Agilent Technologies Business Overview
  88. 8.15.3 Agilent Technologies Agrobacterium tumefaciens Competent Cells Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Agilent Technologies Agrobacterium tumefaciens Competent Cells Product Portfolio
  90. 8.15.5 Agilent Technologies Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Agrobacterium tumefaciens Competent Cells Value Chain Analysis
  2. 9.1.1 Agrobacterium tumefaciens Competent Cells Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Agrobacterium tumefaciens Competent Cells Sales Mode & Process
  6. 9.2 Agrobacterium tumefaciens Competent Cells Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Agrobacterium tumefaciens Competent Cells Distributors
  9. 9.2.3 Agrobacterium tumefaciens Competent Cells Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.